Cancer

Items 1-10 of 20

Page
per page
Set Descending Direction
  1. BX 795 (TBK Inhibitor)
    CAS  702675-74-9
    BBL-5001
    BBL-5001-M0055 mg
    CHF 231.00
    BBL-5001-M02525 mg
    CHF 499.00
    NEW BX 795 (TBK Inhibitor)
  2. CD38 (human) (rec.) (His) (active) (10µg)
    BBL-2275
    BBL-2275-C01010 µg
    CHF 782.00
    CD38 (human) (rec.) (His) (active) (10µg)
  3. CD38 (human) (rec.) (His) (active) (1µg)
    BBL-2274
    BBL-2274-C0011 µg
    CHF 441.00
    CD38 (human) (rec.) (His) (active) (1µg)
  4. DDX1 (human) (rec.) (His) (active) (100µg)
    BBL-2306
    BBL-2306-C100100 µg
    CHF 1'808.00
    NEW DDX1 (human) (rec.) (His) (active) (100µg)
  5. DDX17 (human) (rec.) (His) (active) (20µg)
    BBL-2310
    BBL-2310-C02020 µg
    CHF 851.00
    NEW DDX17 (human) (rec.) (His) (active) (20µg)
  6. DDX17 (human) (rec.) (His) (active) (2µg)
    BBL-2309
    BBL-2309-C0022 µg
    CHF 509.00
    NEW DDX17 (human) (rec.) (His) (active) (2µg)
  7. DDX3 (human) (rec.) (active) (1000µg)
    BBL-2253
    BBL-2253-M0011 mg
    CHF 6'041.00
    DDX3 (human) (rec.) (active) (1000µg)
  8. DDX3 (human) (rec.) (active) (100µg)
    BBL-2252
    BBL-2252-C100100 µg
    CHF 1'809.00
    DDX3 (human) (rec.) (active) (100µg)
  9. DDX3 (human) (rec.) (active) (10µg)
    BBL-2251
    BBL-2251-C01010 µg
    CHF 600.00
    DDX3 (human) (rec.) (active) (10µg)
  10. DDX5 (human) (rec.) (His) (active) (100µg)
    BBL-2308
    BBL-2308-C100100 µg
    CHF 1'808.00
    NEW DDX5 (human) (rec.) (His) (active) (100µg)

Items 1-10 of 20

Page
per page
Set Descending Direction
© 2017 Adipogen Life Sciences. Pictures: © 2012 Martin Oeggerli. All Rights Reserved.